Centaur Labs Raises $16M+ in Series B Funding to Expand AI-Driven Health Data Annotation Platform
Centaur Labs is dedicated to advancing AI in healthcare by providing accurate and reliable data annotations.
Company Name: Centaur Labs
Location: Boston, MA
Sector: Health Data Annotation, AI
Funding Details: Raised over $16 million in Series B funding. The round was led by SignalFire, with participation from Matrix, Accel, Susa, Omega, Y Combinator, and new investors Samsung Next and Alumni Ventures.
Purpose of Investment: The company plans to use the funds to expand its operations and enhance development efforts.
Product and Innovation: Led by CEO, Centaur Labs accelerates AI development for health and science organizations by providing high-quality data annotations through its network of over 50,000 experts. These experts compete on DiagnosUs, a mobile app, to deliver accurate, multimodal data labels for AI model training, evaluation, monitoring, and feedback. The platform ensures a higher accuracy rate in data annotation compared to in-house teams or outsourced generalists, all while maintaining HIPAA compliance.
Centaur Labs also recently launched an on-demand AI data labeling product, which enables developers to collect expert labels in under an hour, further advancing AI development across the health and science sectors.
About the Company: Centaur Labs is dedicated to advancing AI in healthcare by providing accurate and reliable data annotations. Its innovative platform, driven by expert annotators, ensures organizations can scale their AI models with precision and speed, enabling breakthroughs in health and science.